- Sectors
- Healthcare
Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2.4
-1.8
-1.2
-0.6
0
0.6
1.2
1.8
2.4
>= 3
Largest Companies in This Sector
View More| Name
|
Last Price
|
1Y Target Est.
|
Market Weight
|
Market Cap
|
Day Change %
|
YTD Return
|
Avg. Analyst Rating
|
|---|---|---|---|---|---|---|---|
| 1,286.53 | 1,333.72 | 13.92% | 1.147T | +0.36% | +19.71% | Buy
|
|
| 270.23 | 279.41 | 7.90% | 650.527B | +0.56% | +30.58% | Buy
|
|
| 286.67 | 283.19 | 6.15% | 506.58B | +0.10% | +25.46% | Buy
|
|
| 413.31 | 476.64 | 4.50% | 370.989B | +0.71% | +25.21% | Buy
|
|
| 140.35 | 159.76 | 4.20% | 346.268B | -1.04% | +33.34% | Buy
|
|
| 701.16 | 750.92 | 3.15% | 259.252B | +1.17% | +21.00% | Strong Buy
|
|
| 449.76 | 397.32 | 2.95% | 243.154B | +0.40% | +37.41% | Hold
|
|
| 159.46 | 160.19 | 2.40% | 197.717B | +0.24% | +29.91% | Buy
|
|
| 103.20 | 118.52 | 2.18% | 179.755B | +0.10% | -17.63% | Strong Buy
|
|
| 29.39 | 29.26 | 2.03% | 167.485B | -1.39% | +18.01% | Buy
|
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View More| Name
|
Last Price
|
Net Assets
|
Expense Ratio
|
YTD Return
|
|---|---|---|---|---|
| 179.79 | 43.393B | 0.08% | +16.14% | |
| 334.60 | 21.809B | 0.09% | +16.24% | |
| 215.43 | 11.197B | 0.44% | +27.65% | |
| 155.95 | 10.358B | 0.35% | +27.90% | |
| 109.33 | 4.316B | 0.38% | +12.25% |
Mutual Fund Opportunities
View More| Name
|
Last Price
|
Net Assets
|
Expense Ratio
|
YTD Return
|
|---|---|---|---|---|
| 217.33 | 38.313B | 0.27% | +6.24% | |
| 91.66 | 38.313B | 0.27% | +6.27% | |
| 166.60 | 21.809B | 0.09% | +15.74% | |
| 11.44 | 16.876B | 0.00% | +2.94% | |
| 137.99 | 16.876B | 0.00% | +3.58% |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
-
Analyst Report: Thermo Fisher Scientific Inc.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
RatingPrice Target -
Technical Assessment: Bullish in the Intermediate-Term
When considering investment options based on the technical status of the stock market, it can be helpful to remember some of the best-known thoughts from leaders in the game, especially in topsy-turvy times (such as now).
-
Daily – Vickers Top Insider Picks for 10/28/2026
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
-
Analyst Report: The Cooper Companies, Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
RatingPrice Target






